NeuroBo Pharmaceuticals, Inc. Financial Ratios — NRBO Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-373.25	-99.75	-152.68	-136	-233.07	-233.35	-110.09	-55.5	-44.29
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	24.74	2.45	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	1	6	- -	10	10	- -	- -	- -	- -	- -
ST Debt	1	6	- -	1	9	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	9	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-2.77	-0.9	- -	-0.3	-0.62	-0.01	- -	- -	- -	-0.01
Net Debt/EBITDA	-1.58	-0.39	1.64	0.25	-0.43	0.69	0.34	1.07	2.93	1.41
Total Debt/EBIT	-2.77	-0.9	- -	-0.3	-0.62	-0.01	- -	- -	- -	-0.01
Net Debt/EBIT	-1.58	-0.39	1.64	0.25	-0.43	0.69	0.34	1.07	2.92	1.41
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-5.2	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-5.2	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-5.21	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	2	- -
Common Equity/Total Assets	-165.23	-275.72	-109.24	-317.91	-407.17	-254.7	-606.53	-487.09	-285.59	-475.22
Long-Term Debt/Equity (%)	- -	- -	- -	220.32	- -	0.76	0.97	0.31	- -	0.82
Long-Term Debt/Capital (%)	- -	- -	- -	-17.22	-2.36	-0.26	-0.11	-0.06	- -	-0.13
Long-Term Debt/Total Assets (%)	- -	- -	- -	45.66	3.69	0.65	0.64	0.27	- -	0.6
Total Debt/Equity (%)	-138.79	-51.89	- -	254.71	-72.09	0.94	1.31	0.49	- -	1.22
Total Debt/Capital (%)	454.94	-107.86	- -	-19.91	-160.27	-0.32	-0.14	-0.09	- -	-0.19
Total Debt/Total Assets (%)	211.78	143.07	- -	52.78	250.73	0.8	0.86	0.42	- -	0.89
Net Debt to Equity	-79.1	-22.65	-116.48	-214.03	-50.5	-113.15	-140.07	-112.26	-153.4	-134.46
Net Debt/Capital (%)	-270.97	-29.28	47.05	12.24	-76.07	27.46	13.18	16.7	25.84	17.19
EBITDA	- -	-7	-15	-33	-15	-20	-30	-15	-11	-16
EBITDA-CapEx	- -	-7	-15	-33	-15	-20	-30	-15	-11	-16
Operating Income (Loss)	- -	-7	-15	-33	-15	-20	-30	-15	-11	-16

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	0.36	0.41	5.83	2.89	12.99	6.68	2.73	7.6	2.83	3.76
Current Ratio	0.38	0.41	6	2.97	17.39	6.78	2.89	7.69	2.85	3.78
Quick Ratio	0.36	0.41	5.83	2.89	12.99	6.68	2.73	7.6	2.83	3.76
CFO/Avg Current Liab	- -	-1.11	-1.69	-5.12	-4.37	-6.12	-3.73	-5.17	-1.68	-1.22
Common Equity/Total Assets	-165.23	-275.72	-109.24	-317.91	-407.17	-254.7	-606.53	-487.09	-285.59	-475.22
Long-Term Debt/Equity (%)	- -	- -	- -	220.32	- -	0.76	0.97	0.31	- -	0.82
Long-Term Debt/Capital (%)	- -	- -	- -	-17.22	-2.36	-0.26	-0.11	-0.06	- -	-0.13
Long-Term Debt/Total Assets (%)	- -	- -	- -	45.66	3.69	0.65	0.64	0.27	- -	0.6
Total Debt/Equity (%)	-138.79	-51.89	- -	254.71	-72.09	0.94	1.31	0.49	- -	1.22
Total Debt/Capital (%)	454.94	-107.86	- -	-19.91	-160.27	-0.32	-0.14	-0.09	- -	-0.19
Total Debt/Total Assets (%)	211.78	143.07	- -	52.78	250.73	0.8	0.86	0.42	- -	0.89
CFO/Total Liabilities	-22.18	-32.21	-267.9	-178.44	-84.48	-323.48	-285.9	-687.28	-99.39	-177.15
CFO/CapEx	- -	- -	- -	- -	-4,817	-32.89	-2,691	-5,044.67	- -	-215.98
Altman's Z-Score	-6.76	-10.54	8.09	-6.13	-17.56	5.43	-3.1	-1.1	-4.31	-6.24

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	- -	- -	73	82	11	46	85	28	1	19
- Cash & Cash Equivalents	- -	4	24	18	3	14	10	16	33	22
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	6	- -	10	10	- -	- -	- -	- -	- -
Enterprise Value	- -	3	49	74	18	32	75	12	-33	-3
Total Capital	- -	-6	-27	-50	-6	-37	-66	-82	-96	-108
Total Debt/Capital (%)	454.94	-107.86	- -	-19.91	-160.27	-0.32	-0.14	-0.09	- -	-0.19
Total Debt / EV	1.75	2.29	- -	0.14	0.53	- -	- -	0.01	- -	-0.06
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	73	82	11	46	85	28	1	19
Diluted Enterprise Value	- -	3	49	74	18	32	75	12	-33	-3
EV per Share	274.51	1,832.68	31,484.66	42,777.31	7,787.39	1,466.38	1,112.08	123.6	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-7	-15	-33	-15	-20	-30	-15	-11	-16
TTM Operating Income	- -	-7	-15	-33	-15	-20	-30	-15	-11	-16
TTM Cash Flow to Firm	- -	-5	-11	-27	-14	-7	-11	-15	-10	-11
TTM Free Cash Flow to Firm	- -	-5	-11	-27	-14	-7	-11	-15	-10	-11

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	- -	- -	-6.58	-3.06	-0.77	-6.7	-7.91	-1.87	-0.05	-1.75
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	3	49	74	18	32	75	12	-33	-3
Low Price	- -	- -	43,500	43,200	3,420	1,428	1,156.8	288	4.41	2.89
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-6.18	-3.26	-4.29	-4.83	-5.21	-5.15	-1.05	-1.84
Price/Earnings High	- -	- -	-8.67	-6.68	-10.16	-9.1	-16.39	-11.52	-4.06	-3.09
Price/Earnings Low	- -	- -	-4.49	-2.23	-0.51	-1.46	-2.63	-1.82	-0.04	-1.17
Price/Book Value	- -	- -	-2.69	-1.36	-0.72	-1.24	-1.28	-0.35	-0.01	-0.17
Price/Book Value Average	- -	- -	-3.42	-1.8	-4.28	-2.79	-2.32	-0.96	-0.15	-0.21
Price/Book Value High	- -	- -	-4.79	-3.69	-10.14	-5.26	-7.31	-2.15	-0.59	-0.36
Price/Book Value Low	- -	- -	-2.49	-1.23	-0.51	-0.84	-1.18	-0.34	-0.01	-0.14
Price/Tangible Book Value	- -	- -	3.52	20.85	-0.84	3.72	11.82	1.93	0.03	1.12
Price/Tangible Book Value Average	- -	- -	4.48	27.65	-5.01	8.37	21.45	5.4	0.67	1.38
Price/Tangible Book Value High	- -	- -	6.28	56.67	-11.87	15.78	67.54	12.06	2.61	2.31
Price/Tangible Book Value Low	- -	- -	3.26	18.9	-0.59	2.53	10.85	1.9	0.02	0.88
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-6.58	-3.06	-0.77	-6.49	-7.91	-1.87	-0.05	-1.74
Price/Cash Flow Average	- -	- -	-8.37	-4.05	-4.61	-14.61	-14.35	-5.2	-1.25	-2.13
Price/Cash Flow High	- -	- -	-11.74	-8.3	-10.92	-27.55	-45.2	-11.64	-4.84	-3.57
Price/Cash Flow Low	- -	- -	-6.09	-2.77	-0.54	-4.42	-7.26	-1.84	-0.04	-1.36
Price/Free Cash Flow Average	- -	- -	-8.37	-4.05	-4.61	-15.07	-14.36	-5.21	-1.25	-2.14
Price/Free Cash Flow High	- -	- -	-11.74	-8.3	-10.92	-28.42	-45.22	-11.64	-4.84	-3.59
Price/Free Cash Flow Low	- -	- -	-6.09	-2.77	-0.54	-4.55	-7.26	-1.84	-0.04	-1.36
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-1.58	-0.39	-4.66	-3.04	-4.73	-4.42	-4.87	-4.1	1.64	-0.05
EV/EBITDA High	-1.58	-0.39	-7.18	-6.49	-10.62	-8.94	-16.06	-10.48	-2.04	-1.03
EV/EBITDA Low	-1.58	-0.39	-2.94	-1.99	-0.94	-0.86	-2.3	-0.75	2.88	0.48
EV/EBIT Average	-1.58	-0.39	-4.66	-3.04	-4.73	-4.41	-4.86	-4.08	1.64	-0.05
EV/EBIT High	-1.58	-0.39	-7.18	-6.49	-10.62	-8.93	-16.04	-10.45	-2.04	-1.03
EV/EBIT Low	-1.58	-0.39	-2.94	-1.99	-0.94	-0.86	-2.29	-0.75	2.88	0.48
Last Price	- -	- -	47,040	47,670	4,860	2,100	1,260	292.8	5.74	3.7
High Price	- -	- -	83,880	129,540	68,580	8,910	7,200	1,826.26	510.8	7.6
Enterprise Value Average	- -	3	68	101	73	89	145	62	-19	1
Enterprise Value High	- -	3	106	215	164	180	477	160	23	16
Enterprise Value Low	- -	3	43	66	15	17	68	11	-33	-8

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	3	5
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	5
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	5
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-173.86	-4,684.97	-9,511.97	-19,213.46	-6,733.04	-926.13	-439.09	-158.14	-102.75	-3.13
Operating Income per Share	-173.86	-4,684.97	-9,511.97	-19,213.46	-6,733.04	-926.91	-439.77	-158.64	-102.93	-3.13
Basic EPS, GAAP	-209.15	-7,841.18	-9,677.67	-19,382.25	-6,751.74	-979.1	-439.21	-158.5	-125.91	-2.46
Basic EPS from Cont Ops	-209.15	-5,901.31	-9,440.78	-19,382.25	-6,751.74	-979.1	-439.21	-158.5	-125.91	-2.46
Diluted EPS, GAAP	-209.15	-7,841.18	-9,677.67	-19,382.25	-6,751.74	-979.1	-439.21	-158.5	-125.91	-2.46
Diluted EPS from Cont Ops	-209.15	-5,901.31	-9,440.78	-19,382.25	-6,751.74	-979.1	-439.21	-158.5	-125.91	-2.46
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-127.45	-3,550.98	-7,147.57	-15,603.83	-6,283.04	-323.38	-159.3	-156.94	-105.58	-2.13
Free Cash Flow per Basic Share	-127.45	-3,550.98	-7,147.57	-15,603.83	-6,284.35	-333.21	-159.36	-156.97	-105.58	-2.14
Cash & Equivalents per Share	207.19	2,366.01	15,555.34	10,715.2	1,236.96	638.95	149.31	169.93	300.76	4.42
Book Value per Share	-375.82	-8,091.5	-17,502.91	-35,067.29	-6,762.61	-1,692.93	-984.49	-848.55	-863.32	-21.35
Tangible Book Value per Share	-347.06	-8,091.5	13,354.05	2,285.96	-5,776.52	564.71	106.6	151.37	196.07	3.29

NeuroBo Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)